This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format

Elizabeth Lessey-Morillon, Ph.D.
Cell Therapy CMC Reviewer at CBER, FDA


Dr. Elizabeth Lessey-Morillon received her Ph.D. in Cell and Developmental Biology from the University of North Carolina at Chapel Hill. She did her postdoctoral fellowship at the National Cancer Institute (NCI) at the National Institutes of Health in Bethesda, MD. She then became an NCI/U.S. Food and Drug Administration (FDA) Interagency Oncology Task Force Fellow where she conducted research and regulatory review of cell therapies at the FDA. Dr. Lessey-Morillon is currently a cell therapy product reviewer in Office of Tissues and Advanced Therapies at the Center of Biologics Evaluation and Research at the FDA.

Agenda Sessions

  • KEYNOTE: Bioassay Development for Cell Therapies and Phase Appropriate Assay Choices

  • Live Q&A with FDA